- Practical Approach for the Clinical Use of Dopamine Transporter Imaging
-
Kim JS
- KMID: 2036488
- Nucl Med Mol Imaging.
- 2008 Dec;42(6):425-434.
Dopamine transporter imaging is useful in the diagnosis of Parkinson's disease and the most successful technique in the clinical use of neuroreceptor imaging. Recently, several radiopharmaceuticals including I-123 FP-CIT, Tc-99m... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of F-18 FP-CIT Dual Time Point PET Imaging in Idiopathic Parkinson's Disease
-
Oh JK, Yoo ID, Seo YY, Chung YA, Yoo IR, Kim SH, Song IU
- KMID: 1447620
- Nucl Med Mol Imaging.
- 2011 Dec;45(4):255-260.
PURPOSE: The purpose of this study was to investigate the diagnostic value of dual time point F-18 FP-CIT PET imaging in idiopathic Parkinson's disease (PD). MATERIALS AND METHODS: Twenty-four patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease
-
Jeong E, Oh SY, Pahk K, Lee CN, Park KW, Lee JS, Cheon GJ, Choe JG
- KMID: 1427686
- Nucl Med Mol Imaging.
- 2013 Jun;47(2):73-80.
PURPOSE: The aim of this study was to evaluate the feasibility of FP-CIT PET template-based quantitative analysis on F-18 FP-CIT PET in patients with de novo Parkinson's disease (PD), compared... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging
-
Jin S, Oh M, Oh SJ, Oh JS, Lee SJ, Chung SJ, Lee CS, Kim JS
- KMID: 1427710
- Nucl Med Mol Imaging.
- 2013 Mar;47(1):44-51.
PURPOSE: Dopamine transporter (DAT) imaging can demonstrate presynaptic dopaminergic neuronal loss in Parkinson's disease (PD). However, differentiating atypical parkinsonism (APD) from PD is often difficult. We investigated the usefulness of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Multiple System Atrophy and Early Parkinson's Disease Using (123)I-FP-CIT SPECT
-
Oh SW, Kim YK, Lee BC, Kim BS, Kim JS, Kim JM, Kim SE
- KMID: 2313064
- Nucl Med Mol Imaging.
- 2009 Feb;43(1):10-18.
PURPOSE: We investigated quantification of dopaminergic transporter (DAT) and serotonergic transporter (SERT) on (123)I-FP-CIT SPECT for differentiating between multiple systemic atrophy (MSA) and idiopathic Parkinson's disease (IPD). MATERIALS AND METHODS: N-fluoropropyl-2beta-carbomethoxy-3beta-4-[(123)I]-iodophenylnortropane... -
- CITED
-
- Close
- SHARE
-
- Close
